Xiaoping Wu
Impact in
- Hepatology top 10%
- Liver physiology and pathology
- Speech and Hearing top 10%
- Dysphagia Assessment and Management
Papers in
-
- Liver Disease Diagnosis and Treatment 7
-
- Liver physiology and pathology 4
- Liver Disease and Transplantation 4
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Co-authors
- Ruby L.C. Hoo (3 shared papers)Jingjing Li (2 shared papers)Yue Zhao (1 shared paper)Jing Yao (1 shared paper)Qinglong Guo (1 shared paper)Li Zhao (1 shared paper)Yi Zhang (1 shared paper)Qidong You (1 shared paper)
In The Last Decade
Xiaoping Wu
18 papers receiving 311 citations
Peers
Comparison fields: 5 of 81
- Hepatology 59
- Speech and Hearing 41
- Complementary and alternative medicine 27
- Cancer Research 43
- Pharmacology 38
Countries citing papers authored by Xiaoping Wu
This map shows the geographic impact of Xiaoping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Wu more than expected).
Fields of papers citing papers by Xiaoping Wu
This network shows the impact of papers produced by Xiaoping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Wu. The network helps show where Xiaoping Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 77 | |
| 2 | 2014 | 65 | |
| 3 | 2012 | 41 | |
| 4 | 2019 | 32 | |
| 5 | 2012 | 23 | |
| 6 | 2021 | 14 | |
| 7 | 2017 | 14 | |
| 8 | 2014 | 14 | |
| 9 | 2020 | 13 | |
| 10 | A novel antibody AA98 V(H)/L directed against CD146 efficiently inhibits angiogenesis. | 2008 | 13 |
| 11 | 2014 | 5 | |
| 12 | 2015 | 2 | |
| 13 | 2012 | 1 | |
| 14 | 2017 | 1 | |
| 15 | [Value of three-dimensional digital subtraction angiography in diagnosis and planning endovascular treatment of cerebrovascular diseases]. | 2002 | 1 |
| 16 | 2017 | 1 | |
| 17 | [Studies about the level of CD4+ CD25+ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection]. | 2010 | 1 |
| 18 | 2023 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Xiaoping Wu
Xiaoping Wu is a scholar working on Epidemiology, Hepatology, Pulmonary and Respiratory Medicine, Molecular Biology and Computer Vision and Pattern Recognition, having authored 23 papers that have together received 319 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (4 papers), Liver Disease and Transplantation (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Dysphagia Assessment and Management (2 papers), Cerebrovascular and Carotid Artery Diseases (2 papers), MicroRNA in disease regulation (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Hepatology (59 citations), Speech and Hearing (41 citations), Complementary and alternative medicine (27 citations), Cancer Research (43 citations) and Pharmacology (38 citations). Xiaoping Wu has collaborated with scholars based in China, Hong Kong and Czechia. Frequent co-authors include Ruby L.C. Hoo, Jingjing Li, Yue Zhao, Jing Yao, Qinglong Guo, Li Zhao, Yi Zhang, Qidong You, Na Lu and Dewei Ye. Their work appears in journals such as Molecular Carcinogenesis, Scientific Reports, Archives of Pharmacal Research, Disability and Rehabilitation and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.